Literature DB >> 1478365

Insulin resistance in type 2 (non-insulin-dependent) diabetic patients with hypertriglyceridaemia.

E Widén1, A Ekstrand, C Saloranta, A Franssila-Kallunki, J Eriksson, C Schalin-Jäntti, L Groop.   

Abstract

Hypertriglyceridaemia, which is frequently seen in Type 2 (non-insulin-dependent) diabetes mellitus, is associated with insulin resistance. The connection between hypertriglyceridaemia and insulin resistance is not clear, but could be due to substrate competition between glucose and lipids. To address this question we measured glucose and lipid metabolism in 39 Type 2 diabetic patients with hypertriglyceridaemia, i.e. mean fasting serum triglyceride level equal to or above 2 mmol/l (age 59 +/- 1 years, BMI 27.4 +/- 0.5 kg/m2, HbA1c 8.0 +/- 0.2%, serum triglycerides 3.2 +/- 0.2 mmol/l) and 41 Type 2 diabetic patients with normotriglyceridaemia, i.e. mean fasting serum triglyceride level below 2 mmol/l (age 58 +/- 1 years, BMI 27.0 +/- 0.7 kg/m2, HbA1c 7.8 +/- 0.2%, serum triglycerides 1.4 +/- 0.1 mmol/l). Insulin sensitivity was assessed using a 340 pmol.(m2)-1 x min-1 euglycaemic insulin clamp. Substrate oxidation rates were measured with indirect calorimetry and hepatic glucose production was estimated using a primed (25 microCi)-constant (0.25 microCi/min) infusion of [3-3H]-glucose. Suppression of lipid oxidation by insulin was impaired in patients with hypertriglyceridaemia vs patients with normal triglyceride levels (3.5 +/- 0.2 vs 3.0 +/- 0.2 mumol.kg-1 x min-1; p < 0.05). Stimulation of glucose disposal by insulin was reduced in hypertriglyceridaemic vs normotriglyceridaemic patients (27.0 +/- 1.3 vs 31.9 +/- 1.6 mumol.kg-1 x min-1; p < 0.05) primarily due to impaired glucose storage (9.8 +/- 1.0 vs 14.6 +/- 1.4 mumol.kg-1 x min-1; p < 0.01).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1478365     DOI: 10.1007/bf00401367

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  33 in total

1.  Management of non-insulin-dependent diabetes mellitus in Europe: a concensus view.

Authors:  K G Alberti; F A Gries
Journal:  Diabet Med       Date:  1988-04       Impact factor: 4.359

2.  The assessment of hepatic and peripheral insulin sensitivity in hypertriglyceridemia.

Authors:  W R McKane; A B Stevens; R Woods; W J Andrews; R W Henry; P M Bell
Journal:  Metabolism       Date:  1990-12       Impact factor: 8.694

3.  The role of circulating glucose and triglyceride concentrations and their interactions with other "risk factors" as determinants of arterial disease in nine diabetic population samples from the WHO multinational study.

Authors:  K M West; M M Ahuja; P H Bennett; A Czyzyk; O M De Acosta; J H Fuller; B Grab; V Grabauskas; R J Jarrett; K Kosaka
Journal:  Diabetes Care       Date:  1983 Jul-Aug       Impact factor: 19.112

4.  Role of free fatty acids and insulin in determining free fatty acid and lipid oxidation in man.

Authors:  L C Groop; R C Bonadonna; M Shank; A S Petrides; R A DeFronzo
Journal:  J Clin Invest       Date:  1991-01       Impact factor: 14.808

5.  Glucose clamp technique: a method for quantifying insulin secretion and resistance.

Authors:  R A DeFronzo; J D Tobin; R Andres
Journal:  Am J Physiol       Date:  1979-09

6.  Effect of gemfibrozil treatment in sulfonylurea-treated patients with noninsulin-dependent diabetes mellitus.

Authors:  D C Shen; M M Fuh; S M Shieh; Y D Chen; G M Reaven
Journal:  J Clin Endocrinol Metab       Date:  1991-09       Impact factor: 5.958

7.  Insulin-induced glucose utilization influences triglyceride metabolism.

Authors:  J Bazelmans; P J Nestel; C Nolan
Journal:  Clin Sci (Lond)       Date:  1983-05       Impact factor: 6.124

8.  A microfluorometric method for the determination of free fatty acids in plasma.

Authors:  J Miles; R Glasscock; J Aikens; J Gerich; M Haymond
Journal:  J Lipid Res       Date:  1983-01       Impact factor: 5.922

9.  Plasma glucose and insulin responses to oral glucose in nonobese subjects and patients with endogenous hypertriglyceridemia.

Authors:  G M Reaven; L Mejean; C Villaume; P Drouin; G Debry
Journal:  Metabolism       Date:  1983-05       Impact factor: 8.694

10.  Mechanism of hypertriglyceridaemia in diabetic patients with fasting hyperglycaemia.

Authors:  M Greenfield; O Kolterman; J Olefsky; G M Reaven
Journal:  Diabetologia       Date:  1980-06       Impact factor: 10.122

View more
  4 in total

1.  Characteristics of type 2 diabetes in terms of insulin resistance in Korea.

Authors:  Jong-Suk Park; Chul-Sik Kim; Joo-Young Nam; Dol-Mi Kim; Min-Ho Jo; Jina Park; Chul-Woo Ahn; Bong-Soo Cha; Sung-Kil Lim; Kyung-Rae Kim; Hyun-Chul Lee; Kap-Bum Huh
Journal:  Yonsei Med J       Date:  2005-08-31       Impact factor: 2.759

2.  Effect of testosterone and endurance training on glycogen metabolism in skeletal muscle of chronic hyperglycaemic female rats.

Authors:  E van Breda; H Keizer; H Kuipers; G Kranenburg
Journal:  Br J Sports Med       Date:  2003-08       Impact factor: 13.800

3.  The effect of an antilipolytic agent (acipimox) on the insulin resistance of lipid and glucose metabolism in hypertriglyceridaemic patients.

Authors:  C Saloranta; L Groop; A Ekstrand; A Franssila-Kallunki; M R Taskinen
Journal:  Acta Diabetol       Date:  1994-04       Impact factor: 4.280

Review 4.  Mechanisms Linking COPD to Type 1 and 2 Diabetes Mellitus: Is There a Relationship between Diabetes and COPD?

Authors:  Sangmi S Park; Jessica L Perez Perez; Brais Perez Gandara; Christina W Agudelo; Romy Rodriguez Ortega; Huma Ahmed; Itsaso Garcia-Arcos; Cormac McCarthy; Patrick Geraghty
Journal:  Medicina (Kaunas)       Date:  2022-08-01       Impact factor: 2.948

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.